MDSO stock: buy or sell?

MDSO stock price: $91.61 0.12% At close on August 22nd, 2019

Updated on:
August 22nd, 2019

4

Medidata Solutions shares stayed constant 0.12% to $91.61 yesterday.

Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development.

Should I buy MDSO stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

None of our preferred buy setups matches with Medidata Solutions stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean MDSO will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Medidata Solutions stock a buy?

Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we detected 9 ratings published for MDSO stock in the last month.

Is MDSO a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-6-13SunTrust Banksn/aHold
2019-6-12William BlairOutperformMarket Perform
2019-6-12Piper Jaffray CompaniesOverweightNeutral
2019-6-12JPMorgan Chase & Co.UnderweightNeutral
2019-6-12GuggenheimBuyNeutral
2019-4-24SunTrust BanksBuyHold
2019-4-23Wells Fargo & CoOutperformMarket Perform
2019-1-4Piper Jaffray Companiesn/aOverweight
2019-1-2Leerink Swannn/aMarket Perform

MDSO stock analysis

Daily outlook

Shares of Medidata Solutions stayed constant a tight 0.12% and closed at $91.61.

Medidata Solutions closed yesterday at $91.61 and stayed stable a tight 0.12%. Since SMA100d and SMA200d crossed up on May, MDSO price slid a -1.30%. On April MDSO price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. On April, MDSO hit a new all time high, pushing higher than on April tops. Check different trading setups that use ATHs as triggers.

MDSO stock chart (daily)

Weekly outlook

Medidata Solutions shares stayed steady 0.12% this week, ending at $91.61. With this, it's been 5 climbing weeks in a row, soaring a 0.95%.

Far behind is the all-time high Medidata Solutions hit late April but price is just -7.09% below that top. Since SMA20w and SMA40w crossed up early May, MDSO price slid a -2.51%. Early April MDSO price bounced up over the SMA of 40 weeks that acted as support stopping new slides.

MDSO stock chart (weekly)

MDSO stock price history

MDSO IPO was on June 25th, 2009 at $9.00 per share1. Since then, MDSO stock grew a 917.90%, with a yearly average of 91.80%. If you had invested $1,000 in MDSO stock in 2009, it would worth $9,179.00 today.

1: Adjusted price after possible price splits or reverse-splits.

MDSO stock historical price chart

MDSO stock reached all-time highs on April with a price of $98.60.

MDSO stock price target is $87.60

Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' MDSO stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 2 price forecasts for MDSO stock:
MDSO stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-6-13SunTrust BanksRaises Target$85.00$92.258.5%
2019-1-4Piper Jaffray CompaniesLowers Targetn/a$83.00-
(in average)$85.00$87.603.0%
Moving in a range from $92.25 and $83.00, the price prediction for MDSO stock is $87.60. In average, analysts' outlook on MDSO price target is positive, improving the prediction by a 3.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

Medidata Solutions reported exceptional results for 2018-Q4 on February. Medidata Solutions boosted Earnings per Share (EPS) by 62.50%, beating analysts estimates of $0.16. Medidata Solutions posted $0.26.
MDSO earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a0.14n/a
2017-Q32017-10-260.310.336.5%
2017-Q42018-02-080.310.4132.3%
2018-Q12018-04-190.180.2433.3%
2018-Q22018-07-240.190.2426.3%
2018-Q32018-10-180.150.2140.0%
2018-Q42019-02-120.160.2662.5%
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

In 2018, Medidata Solutions annual sales rocketed an amazing 16.81% to $635.70 M dollars from $544.21 marked in 2017. When comparing 2018 vs 2017, in contrast, profit margin (that is, the net income divided by revenues) remained constant a -0.57% to 8.17%.

MDSO annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$277 M-$17 M6.0%-
2014$335 M21.03%$6.09 M1.8%-63.43%
2015$393 M17.14%$13 M3.4%116.14%
2016$463 M18.06%$29 M6.3%120.12%
2017$544 M17.44%$48 M8.7%64.15%
2018$636 M16.81%$52 M8.2%9.13%

Quarterly financial results

Medidata Solutions posted $167.19 M in sales for 2018-Q4, a 2.31% improvement compared to previous quarter. Reported quarter income marked $14.32 million with a profit margin of 8.56%. Profit margin stepped up a 2.02% compared to previous quarter when profit margin was 6.54%. When comparing sales to same quarter last year, Medidata Solutions sales marked an extraordinary gain and skyrocketed a 16.98%. Looking back to recent quarterly results, Medidata Solutions posted 6 negative quarters in a row.
MDSO quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$137 M-$8 M6.0%-
2017-Q3$140 M1.94%$13 M9.2%55.64%
2017-Q4$143 M2.02%$14 M9.7%7.60%
2018-Q1$149 M4.40%$10 M6.9%-25.27%
2018-Q2$156 M4.50%$17 M10.6%60.67%
2018-Q3$163 M4.81%$11 M6.5%-35.57%
2018-Q4$167 M2.31%$14 M8.6%33.97%
2019-Q1$174 M3.78%$11 M6.4%-22.17%

Medidata Solutions ownership

When you are planning to invest in shares of a stock, it's always worth to check its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Medidata Solutions, 3.80% of all outstanding shares are owned by its staff.

Bearish positions for MDSO stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Medidata Solutions:

MDSOABTORCLSLP
Market cap$5.7 B$148.5 B$181.9 B$650.9 M
Total shares62.3 M1,760.0 M3,420.0 M17.5 M
Float shares57.9 M1,750.0 M2,190.0 M12.2 M
  - Institutional holdings (%)106.9%76.5%58.6%43.0%
  - Insider holdings (%)3.8%0.7%33.4%30.8%
Shares in short selling0.0%0.0%0.0%0.0%

MDSO summary

Thursday, August 22nd, 2019
Open$91.58
Close$91.61
Day range$91.51 - $91.65
Previous close$91.50
Session gain0.12%
Average true range$0.19
50d mov avg$91.08
100d mov avg$89.17
200d mov avg$80.48
Daily pattern
Weekly pattern lt11a

Medidata Solutions performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Medidata Solutions, the comparison is made against , Oracle and Simulations Plus.
Stock3m6m12m
MDSOMedidata Solution...-0.10%21.39%12.17%
ABT10.01%11.69%29.78%
ORCLOracle1.18%2.19%9.76%
SLPSimulations Plus48.60%74.66%82.65%

Medidata Solutions competitors

One check before trading any stock is to review a list of its competitors, in this case for Medidata Solutions. We selected 3 companies as Medidata Solutions competitors as they are in the same industry or have similar market objectives.